Tofacitinib reduces mortality in coronavirus disease 2019 Tofacitinib in COVID-19.
Maslennikov R, Ivashkin V, Vasilieva E, Chipurik M, Semikova P, Semenets V, Russkova T, Levshina A, Grigoriadis D, Magomedov S, Efremova I, Dzhakhaya N.
Maslennikov R, et al. Among authors: ivashkin v.
Pulm Pharmacol Ther. 2021 Aug;69:102039. doi: 10.1016/j.pupt.2021.102039. Epub 2021 May 21.
Pulm Pharmacol Ther. 2021.
PMID: 34023513
Free PMC article.
Clinical Trial.